Manifestations of hypersensitivity to anti-tuberculosis drugs

Y. BENBETKA (Algiers, Algeria), S. Souilah (Algiers, Algeria), A. Fissah (Algiers, Algeria)

Source: International Congress 2018 – Challenges in tuberculosis care
Session: Challenges in tuberculosis care
Session type: Thematic Poster
Number: 2699
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. BENBETKA (Algiers, Algeria), S. Souilah (Algiers, Algeria), A. Fissah (Algiers, Algeria). Manifestations of hypersensitivity to anti-tuberculosis drugs. 2699

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Desensitization therapy for allergic reactions of antituberculous drugs
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010


Evaluation of antituberculous drugs administration
Source: Eur Respir J 2002; 20: Suppl. 38, 547s
Year: 2002

Immunoallergic manifestations of antituberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 505s
Year: 2006

Antituberculosis fixed multi-dose combination and single drug therapy in active tuberculosis: What is about drug hypersensitivity reactions?
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016


Hepatotoxicity due to antituberculosis drug treatment
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II
Year: 2008

Anti-tuberculosis drugs
Source: International Congress 2017 – State of the art session: "Respiratory infections"
Year: 2017


Initial antituberculosis drugs resistance
Source: Eur Respir J 2006; 28: Suppl. 50, 12s
Year: 2006

Rapid oral desensitization to anti-tuberculosis drugs
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010


Monitoring of antituberculous drugs adverse events during the treatment of multidrug-resistant pulmonary tuberculosis
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011


Resistance to second-line anti-tuberculosis drugs: new drug resistant TB treatment problem
Source: Annual Congress 2007 - Drug-resistant and multidrug-resistant tuberculosis
Year: 2007



Predictors of hepatotoxicity among patients with tuberculosis treated with antituberculous medication
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016


Drug lymphocyte stimulation test in the diagnosis of adverse reactions to anti-tuberculosis drugs
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008


Severe adverse effects of antitubercular drugs and patient management
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011


Incidence and timing of hepatotoxicity due to anti-tuberculous treatment
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011

Adverse effects of second-line drugs during the treatment of multidrug resistant tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 650s
Year: 2005

Efficacy of intravenous administration of anti-tuberculosis drugs in patients with multidrug-resistant tuberculosis
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Side-effect in the treatment of pulmonary tuberculosis by first-line drugs
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009

Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis
Source: ERJ Open Res, 3 (3) 00016-2017; 10.1183/23120541.00016-2017
Year: 2017



Management of adverse drug events in TB therapy
Source: Eur Respir Mon 2012; 58: 167-193
Year: 2012